Lipella Pharmaceuticals
LIPO
$0.74
Share price
-0.79%
Change (1 day)
-61.64%
Change (1 year)
Categories
Operating Margin for Lipella Pharmaceuticals (LIPO)
Operating Margin as of May 2024 (TTM): -506.50%
According to Lipella Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -506.50%. At the end of 2021 the company had an Operating Margin of -716.66%.
Operating Margin history for Lipella Pharmaceuticals from 2022 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -716.66% | 12736.43% |
| 2020 | -5.58% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.